↓ Skip to main content

Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment

Overview of attention for article published in Cancer Immunology, Immunotherapy, September 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
twitter
5 X users

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
58 Mendeley
Title
Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment
Published in
Cancer Immunology, Immunotherapy, September 2019
DOI 10.1007/s00262-019-02388-8
Pubmed ID
Authors

Suzanne Ostrand-Rosenberg, Daniel W. Beury, Katherine H. Parker, Lucas A. Horn

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 17%
Student > Ph. D. Student 8 14%
Researcher 7 12%
Student > Master 4 7%
Student > Doctoral Student 3 5%
Other 8 14%
Unknown 18 31%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 17%
Medicine and Dentistry 9 16%
Immunology and Microbiology 7 12%
Agricultural and Biological Sciences 6 10%
Mathematics 1 2%
Other 5 9%
Unknown 20 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2022.
All research outputs
#2,751,904
of 23,776,941 outputs
Outputs from Cancer Immunology, Immunotherapy
#173
of 2,893 outputs
Outputs of similar age
#56,749
of 342,840 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#4
of 43 outputs
Altmetric has tracked 23,776,941 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,893 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,840 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.